Wei Yan-ping, Jiang Tao, Tang Chun-ping
Department of Pharmacology of Chinese Medicine, Department of Experimental Animal Center, Guangdong Pharmaceutical University, Guangzhou 510006.
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2011 Jun;31(6):816-9.
To observe the anti-atherosclerotic effect and its possible mechanisms of Modified Zhenzhu Tiaozhi Capsule (MZTC) in rabbits.
50 rabbits were divided into five groups, i.e., the normal group, the model group, the simvastatin group (3 mg/kg), the high dose MZTC group (1.6 g crude drug/kg), and the low dose MZTC group (1.6 g crude drug/kg), respectively, ten in each group. The atherosclerosis (AS) model was established by feeding rabbits with high fat diet. Corresponding medicines were administrated on the basis of high fat diet for twelve successive weeks. Levels of blood lipids, serum superoxide dismutase (SOD), malondialdehyde (MDA), and nitric oxide (NO) were detected. The area of the aortic tunica intima plaque was determined. The pathological changes of the aorta were observed.
Compared with the model group, serum levels of total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), MDA, and atherosclerotic index (AI) were significantly lowered in the MZTC groups (P<0.05, P<0.01), while serum levels of high-density lipoprotein cholesterol (HDL-C), SOD, and NO obviously increased (P<0.05, P<0.01). Serum levels of TC, TG, LDL-C, and in the MZTC groups were obviously higher than those of the simvastatin group (P<0.01), and there was insignificant difference in other indices. The ratio of the aortic tunica intima plaque percentage to the total tunica intima area was also markedly lower than that of the model group (P<0.05, P<0.01). Results under light microscope indicated the pathological changes of the aorta was obviously attenuated.
MZTC could inhibit the formation and development of AS plaque. Its mechanism might be associated with regulating lipids metabolism, antioxidation, and improving endothelial functions.
观察改良珍珠调脂胶囊(MZTC)对兔动脉粥样硬化的防治作用及其可能机制。
将50只兔分为正常组、模型组、辛伐他汀组(3 mg/kg)、MZTC高剂量组(1.6 g生药/kg)、MZTC低剂量组(0.8 g生药/kg),每组10只。采用高脂饲料喂养建立兔动脉粥样硬化(AS)模型。在高脂饲料喂养基础上连续12周给予相应药物。检测血脂、血清超氧化物歧化酶(SOD)、丙二醛(MDA)及一氧化氮(NO)水平;测定主动脉内膜斑块面积;观察主动脉病理变化。
与模型组比较,MZTC组血清总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)、MDA及动脉粥样硬化指数(AI)明显降低(P<0.05,P<0.01),高密度脂蛋白胆固醇(HDL-C)、SOD及NO明显升高(P<0.05,P<0.01)。MZTC组血清TC、TG、LDL-C水平高于辛伐他汀组(P<0.01),其他指标差异无统计学意义。MZTC组主动脉内膜斑块面积占内膜总面积的比例明显低于模型组(P<0.05,P<0.01)。光镜下结果显示主动脉病理改变明显减轻。
MZTC可抑制AS斑块的形成与发展,其机制可能与调节脂质代谢、抗氧化及改善血管内皮功能有关。